Thomas Coyle - Concepedia

Author

Thomas Coyle

SUNY Upstate Medical University

Also Known As

M J Dupuis, T Coyle, T. Coyle, T. E. Coyle, T.E. Coyle, Thomas Coyle, Thomas E Coyle, Thomas E. Coyle, Thomas E. Coyle

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

SUNY Upstate Medical University Syracuse University State University of New York Duke Medical Center Duke University Hospital

About

Thomas Coyle is an author at SUNY Upstate Medical University specializing in medicine, glioma, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.4K
2	Health Sciences	2	2	44
3	Cell Biology	2	2	68
4	Neurology	2	2	49
5	Immunology	1	1	23

Thomas Coyle

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial Michael Weller, Nicholas Butowski, David Tran, The Lancet Oncology Egfrviii-expressing GlioblastomaNeuro-oncologyAct IvGliomaInternational Phase 3	2017	1.1K
Phase I study of BAY 94‐9027, a PEGylated B‐domain‐deleted recombinant factor VIII with an extended half‐life, in subjects with hemophilia A Thomas Coyle, Mark T. Reding, Jennifer Lin, Journal of Thrombosis and Haemostasis	2014	143
Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia TP Jr Loughran, Thomas Coyle, MP Sherman, Blood	1992	132
Gossypol Treatment of Recurrent Adult Malignant Gliomas Peter Bushunow, Marcus M. Reidenberg, John J. Wasenko, Journal of Neuro-Oncology	1999	125
In vitro andin vivo cytotoxicity of gossypol against central nervous system tumor cell lines Thomas Coyle, Sharon Levante, Michele Shetler, Journal of Neuro-Oncology Neuro-oncologyTumor InnervationMedicineAnti-cancer AgentRadiation Oncology	1994	105
Phase 2 study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastoma David Schiff, Santosh Kesari, John de Groot, Investigational New Drugs Neuro-oncologyHuman FibronectinGliomaMedicinePathology	2014	53
Anticonvulsant usage is associated with an increased risk of procarbazine hypersensitivity reactions in patients with brain tumors David F. Lehmann, Tracy E. Hurteau, Nancy Newman, Clinical Pharmacology & Therapeutics	1997	50
Prototypical HTLV-I/II infection is rare in LGL leukemia Thomas P. Loughran, Michael P. Sherman, Francis W. Ruscetti, Leukemia Research Lgl LeukemiaHematological MalignancyAutoimmune DiseaseHematologyPathology	1994	49
Translocation (3;21) in Philadelphia chromosome—positive chronic myelogenous leukemia prior to the onset of blast crisis Thomas Coyle, Vesna Najfeld American Journal of Hematology	1988	46
Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma David N. Korones, Michal Benita‐Weiss, Thomas Coyle, Cancer	2003	43

Page 1